References
- References
- Kuipers EJ, Thijis JC, Festen HPM. The prevalence of Helicobacter in peptic ulcer disease. Aliment Pharmacol Ther 1996;10 Suppl 1:57–64.
- Blaser MJ. Role of VacA and CagA locus of Helicobacter pylori in human disesase. Aliment Pharmacol Ther 1996;10 Suppl 1:73–7.
- Einsenbarth GS. Type I diabetes mellitus: a cronic autoimmune disease. N Engl J Med 1986;314:1360–8.
- Atkinson MA, Maclaren NK. The pathogenesis of insulindependent diabetes mellitus. N Engl J Med 1994;331:1428–34.
- Larkin JG, Frier BM, Ireland JT. Diabetes mellitus and infection. Postgrad Med J 1985;61:233–7.
- Rayfield ES, Sault M, Keush GT, Brothers MS, Nechemias C, Smith H. Infection and diabetes: the case for glucose control. Am J Med 1982;72:439–50.
- Delamaire M, Maugendre, Moreno M, Le Goff M-C, Allanic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997;14:29–34.
- Moutschen MP, Schenn AJ, Lefebre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 1992;18:187–208.
- Gasbarrini A, Ojetti V, Pitocco D, Franceschi F, Candelli M, Torre ES, et al. Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol 1998;10:469–72.
- Oldenburg B, Diepersloot RJA, Hoekstra JBL. High seropreva- lence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci 1996;41:458–60.
- Gasbarrini A, Ojetti V, Pitocco D, De Luca A, Franceschi F, Candelli M, et al. Insulin-dependent diabetes mellitus affects eradication rate of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1999;10:469–72.
- Jaap AJ, Shore AC, Tooke JE. Relationship of insulin resistance to microvasclar dysfunction of subjects with fasting hypergly- caemia. Diabetologia 1997;40:238–43.
- Campbell IW, Heading RC, Tothill P, Buist TAS, Ewing DJ, Clarke BF. Gastric emptying in diabetic autonomic neuropaty. Gut 1997;18:462–7.
- Zullo A, Rinaldi V, Pugliano F, Diana F, Attili AF. Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study. Am J Gatroenterol 1997;92: 2029–31.
- Buckley MJ, Scanlon C, Mc Gurgan P, O’Morian CA. A validated dyspepsia symptom score. Ital J Gastroenterol Hepatol 1997;29:495–500.
- Gasbarrini G, Pretolani S, Bonvicini F, Gatto MR, Tonelli E, Megraud F, et al. A population based study of H. pylori infection in a European country: the San Marino Study. Relations with gastrointestinal diseases. Gut 1995;36:838–44.
- Borody TJ, Andrews P, Fracchia G, Brandl S, Shortis NP, Bae H. Omeprazole enhances efficacy of triple therapy eradicating Helicobacter pylori. Gut 1995;37:477–81.
- Van Der Hulst RWM, Keller JJ, Rauws EAJ, et al. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996;1:6–19.
- Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simoni P, et al. Short-term low-dose triple therapy for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773–7.
- Cammarota G, Cannizzaro O, Tursi A, et al. One week triple therapy for H. pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxicillin. Aliment Pharmacol Ther 1998;12:539–43.
- Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997;11 Suppl 1:43–53.
- Graham DY. Antibiotic resistance in H. pylori: implication for the therapy. Gastroenterology 1998;115: 1272–7.
- Gwilt PR, Nahhas RR, Tracewell WG. The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans. Clin Pharmacokinet 1991;20:477–90.
- Tooke JE. Microvascular haemodynamics in diabetes mellitus. Clin Sci 1986;70:119–25.
- Keshavarzian A, Iber FL, Vaeth J. Gastric emptying in patients with insulin-requiring diabetes mellitus. Am J Gastroenterol 1987;82:29–35.
- Horowitz M, Wishart JM, Jones KL, Hebbard GS. Gastric emptying in diabetes: an overview. Diabet Med 1996;13:S16–22.
- Groop LC, De Fronzo RA, Luizi L, Melander A. Hyperglycemia and absorption of sulphanylurea drugs. Lancet 89;2:129–30.
- Zatz R, Brenner BM. Pathogenesis of diabetic microangiopathy: the haemodynamic views. Am J Med 1986;80:443–53.
- Kong M-FS-C, Macdonald IA, Tattersall RB. Gastric emptying in diabetes. Diabet Med 1996;13:112–9.
- Harris A. Current regimens for treatment of Helicobacter pylori infection. Br Med Bull 1998;54:195–205.
- Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polimophonuclear leukocyte function and metabolic control of diabetes. Diabetes Care 1992;15:256–60.